Emerald Mutual Fund Advisers Trust’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
Emerald Mutual Fund Advisers Trust's HAE Position: Q3 2024 in Review
Emerald Mutual Fund Advisers Trust sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 34,280 shares — an estimated $2.84M sold.
Emerald Mutual Fund Advisers Trust first reported a position in HAE in Q4 2018 and held it in 17 quarters. The position peaked at $27.5M in Q4 2019. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.
- Emerald Mutual Fund Advisers Trust reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 34,280 Haemonetics shares in Q3 2024, an estimated $2.84M.
- Emerald Mutual Fund Advisers Trust first reported a position in Haemonetics in Q4 2018 and held it in 17 quarters.
- Emerald Mutual Fund Advisers Trust's Haemonetics position peaked at $27.5M in Q4 2019.
- 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2024, filed 29 Oct 2024.